01 1Zhejiang Huahai Pharmaceutical
01 1GABAPENTIN USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-06-28
Pay. Date : 2021-12-27
DMF Number : 36241
Submission : 2021-11-19
Status : Active
Type : II
20
Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is GABAPENTIN USP, with a corresponding US DMF Number 36241.
Remarkably, this DMF maintains an Active status since its submission on November 19, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 28, 2023, and payment made on December 27, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
